Holen Sie sich die Stockscreener-App
63.85
2.74%
-1.80
Handel nachbörslich:
49.50
-14.35
-22.47%
Schlusskurs vom Vortag:
$65.65
Offen:
$65.54
24-Stunden-Volumen:
2.59M
Relative Volume:
1.42
Marktkapitalisierung:
$3.39B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.99M
KGV:
-21.31
EPS:
-2.9966
Netto-Cashflow:
$-24.94M
1W Leistung:
-7.01%
1M Leistung:
+7.84%
6M Leistung:
-15.13%
1J Leistung:
+13.73%
1-Tages-Spanne:
$63.75
$67.42
1-Wochen-Bereich:
$63.75
$72.80
52-Wochen-Spanne:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Firmenname
Soleno Therapeutics Inc
Sektor
Branche
Telefon
650-213-8444
Adresse
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Vergleichen Sie SLNO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
63.85 | 3.49B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Eingeleitet | Goldman | Buy |
| 2025-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-06-23 | Eingeleitet | TD Cowen | Buy |
| 2025-03-05 | Fortgesetzt | Stifel | Buy |
| 2024-12-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-12-02 | Bestätigt | Stifel | Buy |
| 2024-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-05 | Eingeleitet | Piper Sandler | Overweight |
| 2024-01-23 | Eingeleitet | Stifel | Buy |
| 2023-11-21 | Fortgesetzt | Guggenheim | Buy |
| 2020-09-29 | Eingeleitet | Guggenheim | Buy |
| 2020-01-10 | Eingeleitet | Craig Hallum | Buy |
| 2019-12-23 | Eingeleitet | Oppenheimer | Outperform |
| 2018-02-13 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten
Soleno Therapeutics Achieves Profitability with VYKAT XR Launch - TipRanks
Earnings call transcript: Soleno Therapeutics Q3 2025 earnings beat expectations - Investing.com
Soleno Therapeutics tumbles despite Q3 earnings, revenue beat By Investing.com - Investing.com UK
Soleno Therapeutics Turns A Profit Thanks To VYKAT XR - Finimize
Soleno Therapeutics tumbles despite Q3 earnings, revenue beat - Investing.com
SOLENO THERAPEUTICS INC SEC 10-Q Report - TradingView
Earnings Flash (SLNO) Soleno Therapeutics, Inc. Reports Q3 Revenue $66.0M, vs. FactSet Est of $48.1M - MarketScreener
Soleno Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on U.S. Launch of VYKAT(TM) XR - The Manila Times
Full technical analysis of Soleno Therapeutics Inc. stock2025 Macro Impact & Verified Momentum Stock Ideas - newser.com
Can Soleno Therapeutics Inc. stock outperform in 2025 bull marketWeekly Investment Report & Weekly Stock Performance Updates - newser.com
Real time social sentiment graph for Soleno Therapeutics Inc.July 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Will Soleno Therapeutics Inc. (6XC) stock outperform small cap peersJuly 2025 Macro Moves & Weekly High Return Stock Forecasts - newser.com
Is Soleno Therapeutics Inc. stock a smart buy before Fed meetingAnalyst Upgrade & Scalable Portfolio Growth Methods - newser.com
Is Soleno Therapeutics Inc. (6XC) stock good for long term investingAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
Published on: 2025-11-04 00:54:52 - newser.com
Strategies to average down on Soleno Therapeutics Inc.Quarterly Portfolio Summary & Growth Oriented Trading Recommendations - newser.com
Soleno Therapeutics Q3 Earnings Preview - MSN
Hot Picks: Investor highlights small-cap opportunities in energy, industrial tech and biotech - BNN Bloomberg
Has Soleno Therapeutics Inc. formed a bullish divergence2025 Top Decliners & Reliable Entry Point Alerts - newser.com
Published on: 2025-11-03 08:08:49 - newser.com
Soleno Therapeutics Inc (SLNO) Q3 2025 Earnings Report Preview: What To Look For - GuruFocus
Will Soleno Therapeutics Inc. stock reach Wall Street targetsTrade Risk Assessment & Consistent Income Trade Recommendations - newser.com
What data driven models say about Soleno Therapeutics Inc.’s future2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Will Soleno Therapeutics Inc. outperform the marketJuly 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
How moving averages guide Soleno Therapeutics Inc. tradingAnalyst Downgrade & Long-Term Safe Investment Plans - newser.com
Order flow analysis tools used on Soleno Therapeutics Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
What hedge fund activity signals for Soleno Therapeutics Inc. stock2025 Trade Ideas & Real-Time Volume Analysis Alerts - newser.com
Moody Aldrich Partners LLC Has $3.48 Million Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
How Soleno Therapeutics Inc. stock benefits from strong dollarJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Soleno Therapeutics, Inc. $SLNO Shares Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Is Soleno Therapeutics Inc. a candidate for recovery play2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Is Soleno Therapeutics Inc. stock a bargain at current levelsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Will Soleno Therapeutics Inc. stock benefit from upcoming earnings reportsMarket Risk Summary & Daily Market Momentum Tracking - newser.com
Soleno Therapeutics (SLNO): Assessing Valuation Following Securities Probe and Short-Seller Safety Allegations - Sahm
Will Soleno Therapeutics Inc. stock outperform tech sector in 2025Portfolio Return Report & Safe Entry Zone Identification - newser.com
Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):